Patent · US Active

Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line

US9029091B2 · kind B2 · utility

0Cited by
16References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 16, 2012
Grant dateMay 12, 2015
Priority date
Expiry dateNov 21, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/6803
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a structural characterization platform that can be used to assess the stability of a polyclonal cell line during production, as well as batch-to-batch consistency of the final polyclonal products. The structural characterization platform is based on genetic analysis as well as protein characterization techniques that alone or in combination provides the necessary information to characterize the polyclonal cell line and final products. The collection of different homologous proteins to be analyzed with the platform techniques is for example a recombinant polyclonal antibody or a mixture of monoclonal antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.